Literature DB >> 30668910

Incorporation of a Synthetic Amino Acid into dCas9 Improves Control of Gene Silencing.

Balwina Koopal1, Aleksander J Kruis1, Nico J Claassens1, Franklin L Nobrega1, John van der Oost1.   

Abstract

The CRISPR-Cas9 nuclease has been repurposed as a tool for gene repression (CRISPRi). This catalytically dead Cas9 (dCas9) variant inhibits transcription by blocking either initiation or elongation by the RNA polymerase complex. Conditional control of dCas9-mediated repression has been achieved with inducible promoters that regulate the expression of the dcas9 gene. However, as dCas9-mediated gene silencing is very efficient, even slightly leaky dcas9 expression leads to significant background levels of repression of the target gene. In this study, we report on the development of optimized control of dCas9-mediated silencing through additional regulation at the translation level. We have introduced the TAG stop codon in the dcas9 gene in order to insert a synthetic amino acid, l-biphenylalanine (BipA), at a permissive site in the dCas9 protein. In the absence of BipA, a nonfunctional, truncated dCas9 is produced, but when BipA is present, the TAG codon is translated resulting in a functional, full-length dCas9 protein. This synthetic, BipA-containing dCas9 variant (dCas9-BipA) could still fully repress gene transcription. Comparison of silencing mediated by dCas9 to dCas9-BipA revealed a 14-fold reduction in background repression by the latter system. The here developed proof-of-principle system thus reduces unwanted background levels of gene silencing, allowing for tight and timed control of target gene expression.

Entities:  

Keywords:  CRISPR-Cas; CRISPRi; Cas9; gene silencing; synthetic amino acid

Year:  2019        PMID: 30668910     DOI: 10.1021/acssynbio.8b00347

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  3 in total

Review 1.  CRISPR Tools To Control Gene Expression in Bacteria.

Authors:  Antoine Vigouroux; David Bikard
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-01       Impact factor: 11.056

2.  Terminal Uridylyl Transferase Mediated Site-Directed Access to Clickable Chromatin Employing CRISPR-dCas9.

Authors:  Jerrin Thomas George; Mohd Azhar; Meghali Aich; Dipanjali Sinha; Uddhav B Ambi; Souvik Maiti; Debojyoti Chakraborty; Seergazhi G Srivatsan
Journal:  J Am Chem Soc       Date:  2020-07-28       Impact factor: 15.419

3.  Modulating CRISPR-Cas Genome Editing Using Guide-Complementary DNA Oligonucleotides.

Authors:  Thomas Swartjes; Peng Shang; Dennis T M van den Berg; Tim Künne; Niels Geijsen; Stan J J Brouns; John van der Oost; Raymond H J Staals; Richard A Notebaart
Journal:  CRISPR J       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.